Prof Ben Parker, a consultant rheumatologist at Manchester Royal Infirmary, expressed optimism about the new CAR T-cell therapy for lupus, stating, "This therapy has the potential to change that, which is incredibly exciting." He emphasized its capability to possibly revolutionize treatment for lupus, a condition that typically necessitates lifelong medication.
The new CAR T-cell therapy, until now mainly used in cancer treatments, enables patients' immune systems to recognize and attack dysfunctional cells. Researchers are optimistic it can provide potential cures for other diseases, marking a significant milestone in lupus research.
Collection
[
|
...
]